Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.66 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.40 |
| ▸ | LAP3 | P28838 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28013609 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL21541952 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL30409620 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL28974319 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL22471729 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL23581995 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL22129973 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL21496268 | 1.00 | SMPD1 (0.66) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL6783963 | 0.98 | SMPD1 (0.63) | SMPD1PTPN1FDPSTSHRHPGD | |
| SCHEMBL6791410 | 0.94 | SMPD1 (0.56) | SMPD1PTPN1FDPSTSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3804688-B1 | ONE PACK-TYPE DENTAL ADHESIVE COMPOSITION | SHOFU INC (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-11602490-B2 | One pack-type dental adhesive composition | SHOFU INC. (JP) | 2023-03-14 | — | — | US | disclosed |
| US-11207247-B2 | Low water-sensitive dental composition | SHOFU INC. (JP) | 2021-12-28 | — | — | US | disclosed |
| US-11033465-B2 | Dental adhesive composition including chain transfer agent | SHOFU INC. (JP) | 2021-06-15 | — | — | US | disclosed |
| EP-3566689-B1 | DENTAL ADHESIVE COMPOSITION INCLUDING CHAIN TRANSFER AGENT | SHOFU INC (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-20210007938-A1 | LOW WATER-SENSITIVE DENTAL COMPOSITION | SHOFU INC. (JP) | 2021-01-14 | — | — | US | disclosed |
| EP-3733151-A1 | LOW-WATER-SENSITIVE DENTAL COMPOSITION | Shofu Inc. (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-3566689-A2 | DENTAL ADHESIVE COMPOSITION INCLUDING CHAIN TRANSFER AGENT | Shofu Inc. (JP) | 2019-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210007938-A1 | LOW WATER-SENSITIVE DENTAL COMPOSITION | MGMT, DNMT3A, TAS2R1 | SMPD1 2923/4885PTPN1 1147/4885FDPS 4053/4885 |
| US-11207247-B2 | Low water-sensitive dental composition | MGMT, DNMT3A, TAS2R1 | SMPD1 2923/4885PTPN1 1147/4885FDPS 4053/4885 |
| US-11602490-B2 | One pack-type dental adhesive composition | ITGA1, TAS2R1, ITGB1 | SMPD1 3122/4885PTPN1 2594/4885FDPS 3465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.